These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4958157)

  • 1. A preliminary study of Lilly 51641.
    Simpson GM; Iqbal J; Iqbal F
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):400-5. PubMed ID: 4958157
    [No Abstract]   [Full Text] [Related]  

  • 2. Procaine: a monoamine oxidase inhibitor in schizophrenia.
    Bucci L
    Dis Nerv Syst; 1973; 34(7):389-91. PubMed ID: 4782297
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of monoamine oxidase inhibitors in schizophrenia.
    Brenner R; Shopsin B
    Biol Psychiatry; 1980 Aug; 15(4):633-47. PubMed ID: 7397294
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs, diagnosis, and disease.
    Gershon S; Angrist B; Shopsin B
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():85-100. PubMed ID: 1219953
    [No Abstract]   [Full Text] [Related]  

  • 5. Are MAOI and other psychotropic drugs really compatible?
    Man PL; Aleem A
    Br J Psychiatry; 1972 Jan; 120(554):120-1. PubMed ID: 5041510
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy and problems of parkinsonism].
    Albert E
    Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900
    [No Abstract]   [Full Text] [Related]  

  • 7. The administration of methionine to chronic schizophrenic patients: a review of ten studies.
    Cohen SM; Nichols A; Wyatt R; Pollin W
    Biol Psychiatry; 1974 Apr; 8(2):209-25. PubMed ID: 4601948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 9. The mono-amine oxidase inhibitors; their usefulness and their safety.
    Bucci L
    Dis Nerv Syst; 1969 Dec; 30(12):843-7. PubMed ID: 5369136
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamino oxidase inhibitors and schizophrenia.
    Bucci L
    Dis Nerv Syst; 1967 Jan; 28(1):55-9. PubMed ID: 5334844
    [No Abstract]   [Full Text] [Related]  

  • 11. Mono-amine oxidase inhibitors and schizophrenia.
    Price J; Hopkinson G
    Psychiatr Clin (Basel); 1968; 1(2):65-84. PubMed ID: 4878603
    [No Abstract]   [Full Text] [Related]  

  • 12. The psychiatrist and MAO inhibitors.
    Bucci L
    Dis Nerv Syst; 1968 Feb; 29(2):127-30. PubMed ID: 5637593
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant neuroleptic syndrome].
    Bjørndal N; Remvig J; Gottlieb P
    Ugeskr Laeger; 1983 Feb; 145(8):570-3. PubMed ID: 6134367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cannabis/neuroleptics interaction in schizophrenic patients].
    Knudsen P; Vilmar T
    Ugeskr Laeger; 1984 Apr; 146(17):1286-91. PubMed ID: 6147913
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychoses in chronic ephedrine addiction].
    Eggert Hansen C
    Nord Med; 1968 Nov; 80(46):1545-9. PubMed ID: 5706259
    [No Abstract]   [Full Text] [Related]  

  • 16. [A recurrent case of psychotic withdrawal syndrome caused by monoamine oxidase inhibitors?].
    Sáez I; Jiménez F
    Med Clin (Barc); 1984 May; 82(19):864-5. PubMed ID: 6738220
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250").
    Varga E; Tringer L
    Acta Med Acad Sci Hung; 1967; 23(3):289-95. PubMed ID: 6056555
    [No Abstract]   [Full Text] [Related]  

  • 18. The dyskenesias: a new therapeutic approach.
    Bucci L
    Dis Nerv Syst; 1971 May; 32(5):324-7. PubMed ID: 4931496
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.
    Jimerson DC; Post RM; Stoddard FJ; Gillin JC; Bunney WE
    Biol Psychiatry; 1980 Feb; 15(1):45-57. PubMed ID: 7357058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and the treatment of psychoses over the last three decades.
    Varga E; Haits G
    Act Nerv Super (Praha); 1968 May; 10(2):126-31. PubMed ID: 5728273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.